GlassScriptPrepare for your visit
Arif I Dalvi
Neurology (Psychiatry & Neurology) · Boynton Beach, FL · NPI 1659422632
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$147,142.85
in general payments reported to CMS, 2019-2025 · $17K in 2025
The $17K reported for 2025 was more than what 92% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Acadia Pharmaceuticals INC $110,025.12
- Biogen, INC. $14,985.33
- Mdd US Operations, LLC $5,053.93
- Insightec,INC $4,334.73
- Abbott Laboratories $3,992.11
- Eisai INC. $2,310.57
Drugs and devices associated with these payments
Nuplazid Exablate Leqembi Percept PC Brainsense Gocovri Rexulti Infinity Xeomin Activa PC Apokyn
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Arif Dalvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/257245/arif-i-dalvi